![Collette Coll](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Collette Coll
Geschäftsführer bei Celleron Therapeutics Ltd.
Aktive Positionen von Collette Coll
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Geschäftsführer | - | - |
Ingenox Therapeutics Ltd.
![]() Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue. | Geschäftsführer | - | - |
Argonaut Therapeutics Ltd.
![]() Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom. | Geschäftsführer | - | - |
Karriereverlauf von Collette Coll
Statistik
International
Vereinigtes Königreich | 4 |
Operativ
Chief Operating Officer | 3 |
Sektoral
Health Technology | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Health Technology |
Ingenox Therapeutics Ltd.
![]() Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue. | Health Services |
Argonaut Therapeutics Ltd.
![]() Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Collette Coll
- Erfahrung